Cart
sales@molnova.com
COH34 analog 1
CAS No. 314248-24-3
COH34 analog 1( —— )
Catalog No. M32852 CAS No. 314248-24-3
COH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | In Stock |
|
| 10MG | 44 | In Stock |
|
| 25MG | 91 | In Stock |
|
| 50MG | 145 | In Stock |
|
| 100MG | 233 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCOH34 analog 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCOH34 analog 1 is a COH34 oxidation analogue that can be used to synthesize active compounds.
-
DescriptionCOH34 analog 1, a metabolite, is an oxidized analog of COH34. COH34 is a potent poly(ADP-ribose) glycohydrolase (PARG) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number314248-24-3
-
Formula Weight325.38
-
Molecular FormulaC18H15NO3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (307.33 mM; Ultrasonic )
-
SMILESCc1ccc(cc1)S(=O)(=O)\N=C\c1c(O)ccc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen SH, et al. Targeting dePARylation selectively suppresses DNA repair-defective and PARP inhibitor-resistant malignancies. Sci Adv. 2019 Apr 10;5(4):eaav4340.?
molnova catalog
related products
-
Camelliaside A
Camelliaside A is a compound with the anti-inflammatory effect.
-
25-Methoxyginsenosid...
2977279-15-3
-
Sodium Hyaluronate
Hyaluronic acid (HA) is an anionic nonsulfated glycosaminoglycan distributed widely throughout connective epithelial and neural tissues. It is unique among glycosaminoglycans in that it is nonsulfated forms in the plasma membrane instead of the Golgi and can be very large with its molecular weight often reaching the millions.
